Digest Network Come funziona
Digest / Comunicato

RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA +12.5%, ADJUSTED NET INCOME +8.4%. PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS

Compatibilità
Salva(0)
Condividi
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA +12.5%, ADJUSTED NET INCOME +8.4%. PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS
Materiali Allegati (1)

216_150251_2025_oneinfo.pdf

Scarica Press Kit ->
Recapiti

Comunicati correlati

13/02/2025
Biotecnologia
Pubblicità/Marketing/Media/Comunicazione
Annunci Economici
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS
Fonte
RECORDATI
Emittente
GLOBENEWSWIRE
Scopri affinità
0
29/07/2025
Biotecnologia
Pubblicità/Marketing/Media/Comunicazione
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%
Fonte
RECORDATI
Emittente
GLOBENEWSWIRE
Scopri affinità
0
28/04/2025
Biotecnologia
Pubblicità/Marketing/Media/Comunicazione
Annunci Economici
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION
Fonte
RECORDATI
Emittente
GLOBENEWSWIRE
Scopri affinità
0